Nevro gains on upbeat revenue forecast

Nevro

10/01/2022 13:42

** Shares of medical device maker  NVRO.N  up ~3% at $81
before the bell and are on pace to snap three straight sessions
of losses 
    ** NVRO sees Q4 revenue of ~$102.5 mln, compared to
estimates of $96.6 mln according to Refinitiv IBES  urn:newsml:reuters.com:*:nASA02X2E
    ** Projects FY 2021 revenue to be ~$386.6 mln, above
estimates of $380.7 mln 
    ** NVRO says it expects to exceed high end of its prior Q4
adjusted EBITDA guidance range urn:newsml:reuters.com:*:nASA02RAF
    ** NVRO shares fell ~53% in 2021

 (Reporting by Deborah Sophia in Bengaluru)
 ((DeborahMary.Sophia@thomsonreuters.com;))